FDA Panel to Convene on PMA for Cartiva’s Synthetic Cartilage Implant

On 4/20/16, FDA's Orthopaedic and Rehabilitation Devices Panel will meet regarding the PMA for Cartiva's Synthetic Cartilage Implant (SCI), an organic polymer-based biomaterial designed to mimic biologic cartilage.

SCI is to be indicated for treatment of degenerative and post-traumatic arthritis in the first metatarsophalangeal joint, in the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us